[Evidence under scrutiny. Neuraminidase inhibitors in severe influenza: yes or no?].
Identifieur interne : 000124 ( Main/Exploration ); précédent : 000123; suivant : 000125[Evidence under scrutiny. Neuraminidase inhibitors in severe influenza: yes or no?].
Auteurs : Angelika BischoffSource :
- MMW Fortschritte der Medizin [ 1438-3276 ] ; 2015.
Descripteurs français
- KwdFr :
- Allemagne, Analyse de survie, Antiviraux (usage thérapeutique), Cause de décès, Grippe humaine (), Grippe humaine (diagnostic), Grippe humaine (mortalité), Grippe humaine (traitement médicamenteux), Hospitalisation, Humains, Médecine factuelle, Oséltamivir (usage thérapeutique), Sialidase (antagonistes et inhibiteurs), Soins ambulatoires, Zanamivir (usage thérapeutique).
- MESH :
- antagonistes et inhibiteurs : Sialidase.
- diagnostic : Grippe humaine.
- mortalité : Grippe humaine.
- traitement médicamenteux : Grippe humaine.
- usage thérapeutique : Antiviraux, Oséltamivir, Zanamivir.
- Allemagne, Analyse de survie, Cause de décès, Grippe humaine, Hospitalisation, Humains, Médecine factuelle, Soins ambulatoires.
- Wicri :
- geographic : Allemagne.
English descriptors
- KwdEn :
- Ambulatory Care, Antiviral Agents (therapeutic use), Cause of Death, Evidence-Based Medicine, Germany, Hospitalization, Humans, Influenza, Human (classification), Influenza, Human (diagnosis), Influenza, Human (drug therapy), Influenza, Human (mortality), Neuraminidase (antagonists & inhibitors), Oseltamivir (therapeutic use), Survival Analysis, Zanamivir (therapeutic use).
- MESH :
- chemical , antagonists & inhibitors : Neuraminidase.
- chemical , therapeutic use : Antiviral Agents, Oseltamivir, Zanamivir.
- geographic : Germany.
- classification : Influenza, Human.
- diagnosis : Influenza, Human.
- drug therapy : Influenza, Human.
- mortality : Influenza, Human.
- Ambulatory Care, Cause of Death, Evidence-Based Medicine, Hospitalization, Humans, Survival Analysis.
DOI: 10.1007/s15006-015-3565-5
PubMed: 26759863
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Evidence under scrutiny. Neuraminidase inhibitors in severe influenza: yes or no?].</title>
<author><name sortKey="Bischoff, Angelika" sort="Bischoff, Angelika" uniqKey="Bischoff A" first="Angelika" last="Bischoff">Angelika Bischoff</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:26759863</idno>
<idno type="pmid">26759863</idno>
<idno type="doi">10.1007/s15006-015-3565-5</idno>
<idno type="wicri:Area/Main/Corpus">000102</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000102</idno>
<idno type="wicri:Area/Main/Curation">000102</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000102</idno>
<idno type="wicri:Area/Main/Exploration">000102</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Evidence under scrutiny. Neuraminidase inhibitors in severe influenza: yes or no?].</title>
<author><name sortKey="Bischoff, Angelika" sort="Bischoff, Angelika" uniqKey="Bischoff A" first="Angelika" last="Bischoff">Angelika Bischoff</name>
</author>
</analytic>
<series><title level="j">MMW Fortschritte der Medizin</title>
<idno type="ISSN">1438-3276</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Ambulatory Care</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Cause of Death</term>
<term>Evidence-Based Medicine</term>
<term>Germany</term>
<term>Hospitalization</term>
<term>Humans</term>
<term>Influenza, Human (classification)</term>
<term>Influenza, Human (diagnosis)</term>
<term>Influenza, Human (drug therapy)</term>
<term>Influenza, Human (mortality)</term>
<term>Neuraminidase (antagonists & inhibitors)</term>
<term>Oseltamivir (therapeutic use)</term>
<term>Survival Analysis</term>
<term>Zanamivir (therapeutic use)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Allemagne</term>
<term>Analyse de survie</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Cause de décès</term>
<term>Grippe humaine ()</term>
<term>Grippe humaine (diagnostic)</term>
<term>Grippe humaine (mortalité)</term>
<term>Grippe humaine (traitement médicamenteux)</term>
<term>Hospitalisation</term>
<term>Humains</term>
<term>Médecine factuelle</term>
<term>Oséltamivir (usage thérapeutique)</term>
<term>Sialidase (antagonistes et inhibiteurs)</term>
<term>Soins ambulatoires</term>
<term>Zanamivir (usage thérapeutique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Neuraminidase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term>
<term>Oseltamivir</term>
<term>Zanamivir</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Germany</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Sialidase</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term>
<term>Oséltamivir</term>
<term>Zanamivir</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Ambulatory Care</term>
<term>Cause of Death</term>
<term>Evidence-Based Medicine</term>
<term>Hospitalization</term>
<term>Humans</term>
<term>Survival Analysis</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Allemagne</term>
<term>Analyse de survie</term>
<term>Cause de décès</term>
<term>Grippe humaine</term>
<term>Hospitalisation</term>
<term>Humains</term>
<term>Médecine factuelle</term>
<term>Soins ambulatoires</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Allemagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26759863</PMID>
<DateCompleted><Year>2016</Year>
<Month>02</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>09</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1438-3276</ISSN>
<JournalIssue CitedMedium="Print"><Volume>157</Volume>
<Issue>17</Issue>
<PubDate><Year>2015</Year>
<Month>Oct</Month>
<Day>08</Day>
</PubDate>
</JournalIssue>
<Title>MMW Fortschritte der Medizin</Title>
<ISOAbbreviation>MMW Fortschr Med</ISOAbbreviation>
</Journal>
<ArticleTitle>[Evidence under scrutiny. Neuraminidase inhibitors in severe influenza: yes or no?].</ArticleTitle>
<Pagination><MedlinePgn>24</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bischoff</LastName>
<ForeName>Angelika</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList><PublicationType UI="D016433">News</PublicationType>
</PublicationTypeList>
<VernacularTitle>Evidenz auf dem Prüfstand. Neuraminidasehemmer bei schwerer Grippe: ja oder nein?</VernacularTitle>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>MMW Fortschr Med</MedlineTA>
<NlmUniqueID>100893959</NlmUniqueID>
<ISSNLinking>1438-3276</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>20O93L6F9H</RegistryNumber>
<NameOfSubstance UI="D053139">Oseltamivir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.2.1.18</RegistryNumber>
<NameOfSubstance UI="D009439">Neuraminidase</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>L6O3XI777I</RegistryNumber>
<NameOfSubstance UI="D053243">Zanamivir</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000553" MajorTopicYN="N">Ambulatory Care</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009439" MajorTopicYN="N">Neuraminidase</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="Y">antagonists & inhibitors</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053139" MajorTopicYN="N">Oseltamivir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053243" MajorTopicYN="N">Zanamivir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>1</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>1</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>2</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">26759863</ArticleId>
<ArticleId IdType="doi">10.1007/s15006-015-3565-5</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list></list>
<tree><noCountry><name sortKey="Bischoff, Angelika" sort="Bischoff, Angelika" uniqKey="Bischoff A" first="Angelika" last="Bischoff">Angelika Bischoff</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=ExplorPubmed/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000124 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000124 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= *** parameter Area/wikiCode missing *** |area= ExplorPubmed |flux= Main |étape= Exploration |type= RBID |clé= pubmed:26759863 |texte= [Evidence under scrutiny. Neuraminidase inhibitors in severe influenza: yes or no?]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26759863" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a ExplorPubmed
![]() | This area was generated with Dilib version V0.6.35. | ![]() |